Glyburide and Paranasal sinus hypersecretion - a phase IV clinical study of FDA data
Paranasal sinus hypersecretion is found among people who take Glyburide, especially for people who are male, 60+ old.
The phase IV clinical study analyzes which people take Glyburide and have Paranasal sinus hypersecretion. It is created by eHealthMe based on reports of 36,719 people who have side effects when taking Glyburide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
36,719 people reported to have side effects when taking Glyburide.
Among them, 15 people (0.04%) have Paranasal sinus hypersecretion.
What is Glyburide?
Glyburide has active ingredients of glyburide. It is often used in diabetes. eHealthMe is studying from 37,307 Glyburide users for its effectiveness, alternative drugs and more.
What is Paranasal sinus hypersecretion?
Paranasal sinus hypersecretion is found to be associated with 729 drugs and 393 conditions by eHealthMe.
Number of Glyburide and Paranasal sinus hypersecretion reports submitted per year:
Gender of people who have Paranasal sinus hypersecretion when taking Glyburide *:
- female: 40 %
- male: 60 %
Age of people who have Paranasal sinus hypersecretion when taking Glyburide *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 41.67 %
- 60+: 58.33 %
Common drugs people take besides Glyburide *:
- Lasix: 5 people, 33.33%
- Lyrica: 4 people, 26.67%
- Byetta: 3 people, 20.00%
- Januvia: 3 people, 20.00%
- Zetia: 2 people, 13.33%
- Vitamin C: 2 people, 13.33%
- Metformin: 2 people, 13.33%
- Synthroid: 2 people, 13.33%
- Prinivil: 2 people, 13.33%
- Esbriet: 2 people, 13.33%
Common side effects people have besides Paranasal sinus hypersecretion *:
- Drowsiness: 5 people, 33.33%
- Breathing Difficulty: 5 people, 33.33%
- Feeling Abnormal: 5 people, 33.33%
- White Blood Cell Count Increased: 4 people, 26.67%
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 4 people, 26.67%
- Weight Increased: 4 people, 26.67%
- Acute Kidney Failure: 4 people, 26.67%
- Oedema Peripheral (superficial swelling): 4 people, 26.67%
- Cough: 4 people, 26.67%
- Conjunctivitis (pink eye): 4 people, 26.67%
Common conditions people have *:
- Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 4 people, 26.67%
- Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 13.33%
- High Blood Cholesterol: 2 people, 13.33%
- Urinary Tract Disorder: 1 person, 6.67%
- Thyroid Diseases: 1 person, 6.67%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 6.67%
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 1 person, 6.67%
- Joint Pain: 1 person, 6.67%
- Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 1 person, 6.67%
- Aneurysm (enlargement of an artery caused by a weakening of the artery wall): 1 person, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Glyburide and have Paranasal sinus hypersecretion?Check whether Paranasal sinus hypersecretion is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Paranasal sinus hypersecretion and when was it recovered:
Expand to all the drugs that have ingredients of glyburide:
Alternative drugs to, pros and cons of Glyburide:
- Glyburide (37,307 reports)
Common Glyburide side effects:
Browse all side effects of Glyburide:a b c d e f g h i j k l m n o p q r s t u v w x y z
Paranasal sinus hypersecretion treatments and more:
- Paranasal sinus hypersecretion (4,043 reports)
COVID vaccines that are related to Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion in Moderna COVID Vaccine
- Paranasal sinus hypersecretion in Pfizer BioNTech Covid Vaccine
- Paranasal sinus hypersecretion in Johnson and Johnson Covid Vaccine
Common drugs associated with Paranasal sinus hypersecretion:
All the drugs that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (729 drugs)
Common conditions associated with Paranasal sinus hypersecretion:
All the conditions that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (393 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on glyburide (the active ingredients of Glyburide) and Glyburide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ondansetron Hydrochloride and Nevirapine drug interaction - 5 seconds ago
- Norvasc and Micro-K drug interaction - 8 seconds ago
- Fioricet and Subutex drug interaction - 9 seconds ago
- Namenda and Northera drug interaction - 12 seconds ago
- Cambia and Nausea - 23 seconds ago
- Sulfasalazine and Pancreatitis Acute - 26 seconds ago
- Vitreous Haemorrhage and drugs of ingredients of fluorouracil - 29 seconds ago
- Gabapentin and Fluid Overload - 32 seconds ago
- Robaxin and Zide drug interaction - 37 seconds ago
- Alprostadil and Anaemia - 49 seconds ago